Statin therapy is associated with decreased small, dense low-density lipoprotein levels in patients undergoing peritoneal dialysis

Contributions to Nephrology

Volumn 178, Issue , 2012, Pages 111-115

  Clementi, Anna ^a,c   Kim, Jeong Chul ^a,b,e   Floris, Matteo ^a,b,d   Cruz, Dinna N ^a,b   Garzotto, Francesco ^a,b   Zanella, Monica ^a,b   Nalesso, Federico ^a,b   Brendolan, Alessandra ^a,b   Giavarina, Davide ^a   Soffiatie, Giuliano ^a   Ronco, Claudio ^a,b  

^a SAN BORTOLO HOSPITAL   (Italy)

^b International Renal Research Institute (IRRIV)   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d San Michele Hospital   (Italy)

^e Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862151280     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000337829     Document Type: Article

References (10)

1. Shoji T, Nishizawa Y, Nishitani H, et al: Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis. Metabolism 1991;40:1002- 1008.
2. Hörkkö S, Huttunen K, Läärä E, et al: Effects of three treatment modes on plasma lipids and lipoproteins in uraemic patients. Ann Med 1994;26:271- 282.
3. Baigent C, Landray MJ, Reith C, et al: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo- controlled trial. Lancet 2011;377:2181- 2192.
4. Franceschini G, Cassinotti M, Vecchio G, et al: Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern. Arterioscler Thromb 1994;14:1569- 1575.
5. Kronenberg F, Lingenhel A, Neyer U, et al: Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int Suppl 2003;84:S113- S116.
6. Bredie SJ, Bosch FH, Demacker PN, et al: Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int 2001;21:275- 281.
7. van den Akker JM, Bredie SJ, Diepenveen SH, et al: Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C- reactive protein and in vivo oxidized LDL. J Nephrol 2003;16:238- 244.
8. Lins RL, Matthys KE, Billiouw JM, et al: Lipid and apoprotein changes during atorvastatin up- titration in hemodialysis patients with hypercholesterolemia: a placebo- controlled study. Clin Nephrol 2004;62:287- 294.
9. Rizzo M, Berneis K, Spinas GA, et al: Quantitative and qualitative effects of rosuvastatin on LDL- cholesterol: what is the clinical significance? Int J Clin Pract 2009;63:478- 485.
10. Choi CU, Seo HS, Lee EM, et al: Statins do not decrease small, dense low- density lipoprotein.Tex Heart Inst J 2010;37:421- 428.